Measuring the evolution of online pharmacy education in a national CPD programme, in Scotland, pre-pandemic (2013-14 vs 2018-19)

Educ Prim Care. 2022 Jan;33(1):46-52. doi: 10.1080/14739879.2021.1970026. Epub 2021 Sep 2.

Abstract

Continuing professional development (CPD) is a regulatory requirement for pharmacy professions in Great Britain. Formal CPD is available in various formats including face-to-face, webinar, and e-learning. CPD may be clinical or non-clinical and may be aligned to core services or not. Literature highlights varied preferences for CPD formats and topics, and in Scotland there was a move towards online CPD in the pharmacy profession. This study utilised electronic attendance and completion records of CPD activities from a national CPD provider in Scotland. The aim was to measure and describe the nature of CPD provision and uptake within Pharmacy in Scotland, comparing records from 2013-14 and 2018-19. Thus, benchmarking the nature of CPD before the COVID-19 pandemic resulted in social distancing restrictions. This study identified that the CPD workforce (NES staffing), and CPD opportunities provided, had evolved towards e-learning delivery. Face-to-face courses were fewer (63 reduced to 58) as were webinars (14 reduced to 6). There were fewer attendances in both. e-Learning was accessed four times more frequently in 2018-19 than 2013-14 (4040 vs 922 completions). Service focussed education was popular in both years. Asynchronous e-learning had become a popular method of CPD for the pharmacy profession before the COVID-19 pandemic, while face-to-face courses and webinars were less popular than 5 years previous. Asynchronous and service focussed CPD should be prioritised over synchronous and general CPD. Learner access and participation data should be utilised to predict future learner needs and preference.

Keywords: E-learning; cpd; online learning; pharmacy education; technology enhanced learning.

MeSH terms

  • COVID-19*
  • Education, Pharmacy*
  • Education, Pharmacy, Continuing
  • Humans
  • Pandemics
  • Pharmacy*
  • SARS-CoV-2